|
US5932579A
(en)
|
1996-06-18 |
1999-08-03 |
Affymax Technologies N.V. |
Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
|
|
DE69719385T2
(de)
*
|
1996-06-21 |
2003-12-18 |
Pharmacia & Upjohn Co., Kalamazoo |
Mmp-hemmende thiadiazolylamide
|
|
NZ334729A
(en)
*
|
1996-09-27 |
2001-01-26 |
Upjohn Co |
'Beta'-sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors involved in tissue degradation
|
|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
WO1998039326A1
(en)
*
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
|
|
AR013079A1
(es)
*
|
1997-05-06 |
2000-12-13 |
Smithkline Beecham Corp |
Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
|
|
US6566373B2
(en)
|
1997-05-06 |
2003-05-20 |
Smithkline Beecham Corporation |
Protease inhibitors
|
|
US5883131A
(en)
*
|
1997-07-09 |
1999-03-16 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
KR100352316B1
(ko)
|
1997-07-31 |
2002-09-12 |
더 프록터 앤드 갬블 캄파니 |
메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체
|
|
DE19741235A1
(de)
*
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6403632B1
(en)
|
2000-03-01 |
2002-06-11 |
Bristol Myers Squibb Pharma Co |
Lactam metalloprotease inhibitors
|
|
ZA988967B
(en)
*
|
1997-10-03 |
2000-04-03 |
Du Pont Pharm Co |
Lactam metalloprotease inhibitors.
|
|
US6420427B1
(en)
*
|
1997-10-09 |
2002-07-16 |
Ono Pharmaceutical Co., Ltd. |
Aminobutyric acid derivatives
|
|
EP1004578B1
(en)
*
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
GB9825988D0
(en)
*
|
1998-11-27 |
1999-01-20 |
Pfizer Ltd |
Indole derivatives
|
|
US20040122011A1
(en)
*
|
1998-12-23 |
2004-06-24 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
|
|
WO2000051975A1
(en)
|
1999-03-03 |
2000-09-08 |
The Procter & Gamble Company |
Alkenyl- and alkynyl-containing metalloprotease inhibitors
|
|
PL350452A1
(en)
|
1999-03-03 |
2002-12-16 |
Procter & Gamble |
Dihetero-substituted metalloprotease inhibitors
|
|
EP1165546A2
(en)
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
|
|
US6797820B2
(en)
|
1999-12-17 |
2004-09-28 |
Vicuron Pharmaceuticals Inc. |
Succinate compounds, compositions and methods of use and preparation
|
|
AU2002230385A1
(en)
*
|
2000-09-25 |
2002-04-15 |
Questcor Pharmaceuticals, Inc. |
Peptide deformylase inhibitors
|
|
WO2002055516A2
(en)
|
2001-01-11 |
2002-07-18 |
Bristol Myers Squibb Co |
1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
|
|
EP1355648A2
(en)
|
2001-01-11 |
2003-10-29 |
Bristol-Myers Squibb Pharma Company |
1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
|
|
EP1363623B1
(en)
*
|
2001-03-01 |
2005-11-16 |
Smithkline Beecham Corporation |
Peptide deformylase inhibitors
|
|
AR036053A1
(es)
|
2001-06-15 |
2004-08-04 |
Versicor Inc |
Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
|
|
DK1406893T3
(da)
*
|
2001-06-15 |
2007-08-06 |
Vicuron Pharm Inc |
Bicykliske pyrrolidinforbindelser
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
TWI294778B
(en)
*
|
2002-03-13 |
2008-03-21 |
Smithkline Beecham Corp |
Peptide deformylase inhibitors
|
|
US7622117B2
(en)
*
|
2002-04-17 |
2009-11-24 |
Dynamis Therapeutics, Inc. |
3-deoxyglucosone and skin
|
|
DE60327432D1
(de)
*
|
2002-05-29 |
2009-06-10 |
Merck & Co Inc |
Nützliche verbindungen für die behandlung von anthrax und hemmung des letalen faktors
|
|
US20050176686A1
(en)
*
|
2002-07-23 |
2005-08-11 |
4Sc Ag |
Novel compounds as histone deacetylase inhibitors
|
|
US7846963B2
(en)
*
|
2003-05-17 |
2010-12-07 |
Korea Research Institute Of Bioscience And Biotechnology |
2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
|
|
US7122560B2
(en)
|
2003-06-18 |
2006-10-17 |
Bristol-Myers Squibb Company |
Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
|
|
EP1663201A4
(en)
*
|
2003-07-15 |
2009-10-28 |
Korea Res Inst Of Bioscience |
USE OF NOVEL 2-OXO-HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
|
|
TWI343816B
(en)
*
|
2003-07-23 |
2011-06-21 |
Novartis Ag |
Use of calcitonin in osteoarthritis
|
|
JP2007537256A
(ja)
*
|
2004-05-11 |
2007-12-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｎ−スルホン化アミノ酸誘導体調製のためのプロセス
|
|
US20100003276A1
(en)
*
|
2004-12-07 |
2010-01-07 |
Hermes Jeffery D |
Methods for treating anthrax and inhibiting lethal factor
|
|
DE102004060229A1
(de)
*
|
2004-12-15 |
2006-06-29 |
Sanofi-Aventis Deutschland Gmbh |
Neue zyklische Harnstoffe als Inhibitoren von Metallproteasen
|
|
BRPI0606123A2
(pt)
*
|
2005-01-28 |
2009-06-02 |
Irm Llc |
pirrolidinas fenil-substituìdas
|
|
GB0811643D0
(en)
|
2008-06-25 |
2008-07-30 |
Cancer Rec Tech Ltd |
New therapeutic agents
|
|
FR2947268B1
(fr)
*
|
2009-06-30 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
US9738604B2
(en)
|
2010-09-03 |
2017-08-22 |
Duke University |
Ethynylbenzene derivatives
|
|
US20140081017A1
(en)
*
|
2012-09-14 |
2014-03-20 |
Methylgene Inc. |
Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents
|
|
WO2015024010A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
Substituted hydroxamic acid compounds
|
|
US10189786B2
(en)
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
WO2015024016A2
(en)
*
|
2013-08-16 |
2015-02-19 |
Duke University |
2-piperidinyl substituted n,3-dihydroxybutanamides
|
|
GB201517217D0
(en)
|
2015-09-29 |
2015-11-11 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
|
GB201517216D0
(en)
|
2015-09-29 |
2015-11-11 |
Cancer Res Technology Ltd And Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201704966D0
(en)
|
2017-03-28 |
2017-05-10 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201704965D0
(en)
|
2017-03-28 |
2017-05-10 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|